{"id":"adenosine-triphosphate","rwe":[{"pmid":"41905068","year":"2026","title":"Investigation of the effects and underlying mechanisms of adenylate kinase 1 on inosine monophosphate deposition in Beijing-You chickens.","finding":"","journal":"Poultry science","studyType":"Clinical Study"},{"pmid":"41904006","year":"2026","title":"Understanding the impact of cytoskeleton disruption on synaptic plasticity in Alzheimer's disease.","finding":"","journal":"Advances in protein chemistry and structural biology","studyType":"Clinical Study"},{"pmid":"41902752","year":"2026","title":"Bioinspired Nanofluidic Temperate Synthesis.","finding":"","journal":"Accounts of chemical research","studyType":"Clinical Study"},{"pmid":"41902561","year":"2026","title":"Impact of Slaughter-Induced Stress on Biochemical Deterioration and Flavor Stability of Greater Amberjack (Seriola dumerili) Fillets During Iced Storage.","finding":"","journal":"Journal of food science","studyType":"Clinical Study"},{"pmid":"41902426","year":"2026","title":"Electrostatic Charge Shielding Effect of ATP: Implications for Therapeutic Intervention.","finding":"","journal":"Journal of neurochemistry","studyType":"Clinical Study"}],"_fda":{"id":"7e90559f-51b5-36ff-e053-2a91aa0a9b17","set_id":"119a205d-0074-48ff-ac78-e2300db45227","openfda":{"nui":["N0000193618","M0001797","N0000185375","N0000185371","N0000175629","N0000184306","M0000728","M0006342","M0016962","M0022575","N0000185017"],"upc":["0317089075202"],"unii":["8ID597Z82X","73Y7P0K73Y","OF5471ZHRR","8L70Q75FXE","PQ6CK8PD0R","CUQ3A77YXI","L7A49804ZQ","N487KM8COK","0UV74P3R0J","SAA04E81UX","K848JZ4886","88XHZ13131","33X04XA5AT","0E53J927NA","817L1N4CKP","VZ3U1H7Q5B","O138UB266J","68Y4CF58BV","TLM2976OFR","6CA025Y4FG","POD38AIF08","AB6MNQ6J6L","398IYQ16YV","9928MC12VO","M572600E5P"],"route":["ORAL"],"spl_id":["7e90559f-51b5-36ff-e053-2a91aa0a9b17"],"brand_name":["OMEOSPORT"],"spl_set_id":["119a205d-0074-48ff-ac78-e2300db45227"],"package_ndc":["17089-075-20"],"product_ndc":["17089-075"],"generic_name":[".ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO -"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Ascorbic Acid [CS]","Allergens [CS]","Dietary Proteins [CS]","Plant Proteins [CS]","Vegetable Proteins [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]"],"substance_name":[".ALPHA.-KETOGLUTARIC ACID",".ALPHA.-LIPOIC ACID","ACONITIC ACID, (Z)-","ADENOSINE TRIPHOSPHATE","ASCORBIC ACID","ASIAN GINSENG","BARIUM OXALOSUCCINATE","BEET","CEROUS OXALATE NONAHYDRATE","COENZYME A","CYSTEINE","FUMARIC ACID","LACTIC ACID","MAGNESIUM CARBONATE","MALIC ACID","MANGANESE PHOSPHATE, DIBASIC","PORK","PYRIDOXINE HYDROCHLORIDE","RIBOFLAVIN","SODIUM DIETHYL OXALACETATE","SODIUM PYRUVATE","SUCCINIC ACID","SUS SCROFA ADRENAL GLAND","SUS SCROFA EMBRYO","THIAMINE HYDROCHLORIDE"],"pharm_class_epc":["Vitamin C [EPC]","Non-Standardized Plant Allergenic Extract [EPC]","Non-Standardized Food Allergenic Extract [EPC]"],"manufacturer_name":["Guna spa"],"is_original_packager":[true]},"purpose":["USES For the temporary relief of symptoms related to athletic training and exertion such as: Muscle cramps Sore muscles Lack of endurance"],"version":"2","warnings":["WARNINGS Stop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children."],"questions":["QUESTIONS Questions?: info@gunainc.com tel. (484) 223-3500"],"effective_time":"20181221","active_ingredient":["ACTIVE INGREDIENTS/PURPOSE ADENOSINTRIPHOSPHATE 8X CELL METABOLISM ALPHA-KETOGLUTARIC ACID 6X DETOXIFICATION ALPHA-LIPOIC AC 6X DETOXIFICATION ASCORBIC ACID 4X CELL METABOLISM BARIUM OXALOSUCCINATE 6X DETOXIFICATION BETA VULGARIS 2X CELL METABOLISM CERIUM OXALICUM 6X CELL METABOLISM CIS-ACONITIC ACID 6X CELL METABOLISM COENZYME A 6X CELL METABOLISM CYSTEINUM 6X CELL METABOLISM EMBRYO EXTRACT 6X CELL METABOLISM FUMARICUM ACIDUM 6X ANTI-INFLAMMATORY GINSENG 3X DETOXIFICATION GLANDULA SUPRARENALIS 10X HORMONAL REGULATION LACTICUM ACIDUM 8X CELL METABOLISM MAGNESIUM CARBONATE 2X TIREDNESS MALIC ACID 6X CELL METABOLISM MANGANUM PHOSPHORICUM 6X TIREDNESS MUSCLE TISSUE 6X MUSCLE METABOLISM NATRUM OXALACETICUM 6X CELL METABOLISM NATRUM PYRUVICUM 6X CELL METABOLISM PYRIDOXINUM HYDROCHLORICUM 6X METABOLIC SUPPORT RIBOFLAVINUM 6X CELL METABOLISM SUCCINICUM ACIDUM 6X CELL METABOLISM THIAMINUM HYDROCHLORICUM 4X METABOLIC SUPPORT"],"inactive_ingredient":["Inactive ingredient: Sucrose."],"indications_and_usage":["Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals."],"dosage_and_administration":["DIRECTIONS Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be dissolved into a little water"],"spl_product_data_elements":["OMEOSPORT .ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO - SUCROSE ADENOSINE TRIPHOSPHATE ADENOSINE TRIPHOSPHATE .ALPHA.-KETOGLUTARIC ACID .ALPHA.-KETOGLUTARIC ACID .ALPHA.-LIPOIC ACID .ALPHA.-LIPOIC ACID ASCORBIC ACID ASCORBIC ACID BARIUM OXALOSUCCINATE BARIUM CATION BEET BEET CEROUS OXALATE NONAHYDRATE CEROUS CATION ACONITIC ACID, (Z)- ACONITIC ACID, (Z)- COENZYME A COENZYME A CYSTEINE CYSTEINE SUS SCROFA EMBRYO SUS SCROFA EMBRYO FUMARIC ACID FUMARIC ACID ASIAN GINSENG ASIAN GINSENG SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND LACTIC ACID LACTIC ACID MAGNESIUM CARBONATE CARBONATE ION MALIC ACID MALIC ACID MANGANESE PHOSPHATE, DIBASIC MANGANESE CATION (2+) PORK PORK SODIUM DIETHYL OXALACETATE DIETHYL OXALACETATE SODIUM PYRUVATE PYRUVIC ACID PYRIDOXINE HYDROCHLORIDE PYRIDOXINE RIBOFLAVIN RIBOFLAVIN SUCCINIC ACID SUCCINIC ACID THIAMINE HYDROCHLORIDE THIAMINE ION white"],"pregnancy_or_breast_feeding":["PREGNANCY If pregnant or breast-feeding ask a health professional before use."],"keep_out_of_reach_of_children":["WARNINGS Keep out of reach of children"],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL 5USBIO-Omeosport-rev04-110718"]},"tags":[{"label":"Adenosine Receptor Agonist","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"P2X purinoceptor 3","category":"target"},{"label":"P2RX3","category":"gene"},{"label":"GPR17","category":"gene"},{"label":"P2RX1","category":"gene"},{"label":"Active","category":"status"},{"label":"Supraventricular arrhythmia","category":"indication"},{"label":"Analgesics","category":"pharmacology"},{"label":"Anti-Arrhythmia Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Purinergic Agonists","category":"pharmacology"},{"label":"Purinergic P1 Receptor Agonists","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"},{"label":"Vasodilator Agents","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"ACUTE KIDNEY INJURY","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"ATRIAL FIBRILLATION","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"BLOOD CULTURE POSITIVE","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"HYPOCALCAEMIA","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"HYPONATRAEMIA","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"NEUROMYOPATHY","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"PANCYTOPENIA","source":"FDA FAERS","actionTaken":"2 reports"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ADENOSINE TRIPHOSPHATE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:20:02.455168+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-19T23:20:21.493842+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:20:08.269828+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ADENOSINE TRIPHOSPHATE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:20:08.751189+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:20:01.192529+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:20:01.192564+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:20:01.192569+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-19T23:20:10.961998+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106579/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:20:09.987561+00:00"}},"allNames":"triphosphoric acid adenosine ester","offLabel":[],"synonyms":["adenosine triphosphate","ATP","triphosphoric acid adenosine ester","adenosine triphosphate disodium hydrate"],"timeline":[],"aiSummary":"ADENOSINE TRIPHOSPHATE is a marketed drug used for the treatment of supraventricular arrhythmia, with a key composition patent expiring in 2028. Its mechanism of action, involving the binding to adenosine receptors to slow down abnormal heart rhythms, provides a targeted approach to managing arrhythmias. The primary risk is the upcoming patent expiry, which could lead to increased competition from generic versions.","brandName":"Triphosphoric Acid Adenosine Ester","ecosystem":[{"indication":"Supraventricular arrhythmia","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"target":"P2X purinoceptor 3","targets":[{"gene":"P2RX3","source":"DrugCentral","target":"P2X purinoceptor 3","protein":"P2X purinoceptor 3"},{"gene":"GPR17","source":"DrugCentral","target":"Uracil nucleotide/cysteinyl leukotriene receptor","protein":"Uracil nucleotide/cysteinyl leukotriene receptor"},{"gene":"P2RX1","source":"DrugCentral","target":"P2X purinoceptor 1","protein":"P2X purinoceptor 1"},{"gene":"P2RY2","source":"DrugCentral","target":"P2Y purinoceptor 2","protein":"P2Y purinoceptor 2"},{"gene":"P2RX4","source":"DrugCentral","target":"P2X purinoceptor 4","protein":"P2X purinoceptor 4"},{"gene":"P2RY4","source":"DrugCentral","target":"P2Y purinoceptor 4","protein":"P2Y purinoceptor 4"},{"gene":"P2RY1","source":"DrugCentral","target":"P2Y purinoceptor 1","protein":"P2Y purinoceptor 1"},{"gene":"JAK2","source":"DrugCentral","target":"Tyrosine-protein kinase JAK2","protein":"Tyrosine-protein kinase JAK2"},{"gene":"TRPM4","source":"DrugCentral","target":"Transient receptor potential cation channel subfamily M member 4","protein":"Transient receptor potential cation channel subfamily M member 4"},{"gene":"MAPKAPK2","source":"DrugCentral","target":"MAP kinase-activated protein kinase 2","protein":"MAP kinase-activated protein kinase 2"}],"moaClass":"Adenosine Receptor Agonists","modality":"Small Molecule","drugClass":"Vitamin C [EPC]","explanation":"","oneSentence":"","technicalDetail":"ATP acts as an agonist at the P2X purinoceptor 3, a subtype of adenosine receptor that is involved in the regulation of heart rhythm. By activating this receptor, ATP helps to decrease the heart rate and reduce the force of contraction, which can help to prevent supraventricular arrhythmia."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/91","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ADENOSINE%20TRIPHOSPHATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ADENOSINE TRIPHOSPHATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:28:31.471123","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-19T23:20:21.493931+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"adenosine triphosphate","indications":{"approved":[{"name":"Supraventricular arrhythmia","source":"DrugCentral","snomedId":72654001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03685721","phase":"","title":"Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-10-11","conditions":["Sickle Cell","PKLR Variants","Adenosine Triphosphate Activities"],"enrollment":800,"completionDate":"2026-07-01"},{"nctId":"NCT06016387","phase":"PHASE2","title":"Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-11-25","conditions":["HER2-positive Breast Cancer","LMD"],"enrollment":30,"completionDate":"2028-10-05"},{"nctId":"NCT07296354","phase":"PHASE4","title":"Evaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Egyptian International Pharmaceutical Industries Co","startDate":"2026-01-10","conditions":["Neuropathic Pain"],"enrollment":200,"completionDate":"2029-01-10"},{"nctId":"NCT03119818","phase":"NA","title":"Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-06-14","conditions":["End-Stage Renal Disease (ESRD)"],"enrollment":11,"completionDate":"2017-07-29"},{"nctId":"NCT05488431","phase":"PHASE2","title":"Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)","status":"RECRUITING","sponsor":"Priscilla Hsue, MD","startDate":"2023-03-01","conditions":["Dyslipidemias","Cardiovascular Diseases","HIV Infections","Atherosclerosis"],"enrollment":121,"completionDate":"2028-03-01"},{"nctId":"NCT06662760","phase":"PHASE1","title":"Clinical Trial of TQB3002 in Patients With Advanced Cancers","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-12-09","conditions":["Advanced Cancer"],"enrollment":150,"completionDate":"2026-10"},{"nctId":"NCT07085975","phase":"PHASE1","title":"The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-08-05","conditions":["Chronic Cough (CC)","Asthma"],"enrollment":33,"completionDate":"2026-10-01"},{"nctId":"NCT06181799","phase":"","title":"Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-11-01","conditions":["Coronary Artery Disease","Ischemic Heart Disease","Chronic Coronary Disease","Angina Pectoris","Stable Coronary Artery Disease CAD"],"enrollment":80,"completionDate":"2024-06-10"},{"nctId":"NCT05694260","phase":"PHASE2","title":"A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)","status":"COMPLETED","sponsor":"Esperion Therapeutics, Inc.","startDate":"2023-01-12","conditions":["Hypercholesterolemia"],"enrollment":31,"completionDate":"2025-06-04"},{"nctId":"NCT07064239","phase":"NA","title":"Effect of Cooling Vest in Multiple Sclerosis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-05-20","conditions":["Multiple Sclerosis"],"enrollment":30,"completionDate":"2025-07-08"},{"nctId":"NCT03675893","phase":"PHASE2","title":"RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-12-24","conditions":["Endometrial Cancer","Ovarian Cancer"],"enrollment":180,"completionDate":"2031-08-01"},{"nctId":"NCT06893315","phase":"","title":"Photobiomodulation for Episiotomies and Perineal Lacerations After Vaginal Delivery.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Nove de Julho","startDate":"2024-09-01","conditions":["Perineal Lacerations","Delivery, Obstetric","Episiotomy Wound","Photobiomodulation Therapy","Pain"],"enrollment":183,"completionDate":"2025-07"},{"nctId":"NCT05265871","phase":"","title":"ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough","status":"COMPLETED","sponsor":"Kefang Lai","startDate":"2022-05-16","conditions":["Refractory/Unexplained Chronic Cough"],"enrollment":131,"completionDate":"2024-01-24"},{"nctId":"NCT06112990","phase":"PHASE3","title":"Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-11-09","conditions":["Metastatic Prostate Cancer"],"enrollment":200,"completionDate":"2028-11-30"},{"nctId":"NCT06921720","phase":"NA","title":"Phosphorus-31 Spectroscopy in Phosphate Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-05-01","conditions":["Phosphate Diabetes","X-linked Hypophosphatemia"],"enrollment":65,"completionDate":"2027-05-01"},{"nctId":"NCT01827527","phase":"","title":"Magnetic Resonance & Optical Spectroscopy Validation","status":"RECRUITING","sponsor":"AdventHealth Translational Research Institute","startDate":"2013-03","conditions":["Validation Studies","Magnetic Resonance Spectroscopy"],"enrollment":150,"completionDate":"2025-12"},{"nctId":"NCT01782027","phase":"NA","title":"Mendelian Reverse Cholesterol Transport Study","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2012-10","conditions":["Cholesterol, HDL","Lipid Metabolism, Inborn Errors","Tangier Disease","LCAT Deficiency","Cholesteryl Ester Transfer Protein (CETP) Deficiency"],"enrollment":17,"completionDate":"2024-09-04"},{"nctId":"NCT03722849","phase":"NA","title":"Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough Patients","status":"COMPLETED","sponsor":"Stuart Mazzone","startDate":"2019-03-01","conditions":["Cough"],"enrollment":58,"completionDate":"2022-05-13"},{"nctId":"NCT04336098","phase":"PHASE1","title":"Study of SRF617 in Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Coherus Oncology, Inc.","startDate":"2020-03-16","conditions":["Advanced Solid Tumor"],"enrollment":85,"completionDate":"2023-08-25"},{"nctId":"NCT06434467","phase":"PHASE3","title":"The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-05","conditions":["T-lymphoblastic Leukemia","T-lymphoblastic Lymphoma"],"enrollment":83,"completionDate":"2026-05"},{"nctId":"NCT06363006","phase":"PHASE1","title":"Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-03-11","conditions":["Hepatocellular Carcinoma"],"enrollment":40,"completionDate":"2027-01-01"},{"nctId":"NCT00159315","phase":"NA","title":"ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2002-10","conditions":["Asthma","COPD","Smoking"],"enrollment":31,"completionDate":"2004-10"},{"nctId":"NCT06322355","phase":"","title":"Comparison of UFR With QFR in Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-07-01","conditions":["Coronary Artery Disease"],"enrollment":250,"completionDate":"2023-12-31"},{"nctId":"NCT06266715","phase":"NA","title":"Improvement of Depression With Use of ATP","status":"RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-03-04","conditions":["Depression"],"enrollment":120,"completionDate":"2026-12-31"},{"nctId":"NCT05926466","phase":"PHASE2","title":"BTZ-043 Dose Evaluation in Combination and Selection","status":"UNKNOWN","sponsor":"Michael Hoelscher","startDate":"2023-09-21","conditions":["Tuberculosis, Pulmonary","Other Specified Pulmonary Tuberculosis"],"enrollment":90,"completionDate":"2024-08"},{"nctId":"NCT03225105","phase":"PHASE1","title":"M3541 in Combination With Radiotherapy in Solid Tumors","status":"TERMINATED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2017-09-06","conditions":["Solid Tumors"],"enrollment":15,"completionDate":"2020-04-27"},{"nctId":"NCT05431413","phase":"PHASE2","title":"Rapid Improvement of Depression of Fluoxetine Combined With ATP","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-01-07","conditions":["Depression"],"enrollment":195,"completionDate":"2025-12-30"},{"nctId":"NCT02858921","phase":"PHASE2","title":"Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma","status":"UNKNOWN","sponsor":"Melanoma Institute Australia","startDate":"2017-11-08","conditions":["Melanoma"],"enrollment":60,"completionDate":"2024-11"},{"nctId":"NCT05131191","phase":"","title":"CT-FFR for Coronary In-stent Stenosis Based on ISR-Net Algorithm","status":"UNKNOWN","sponsor":"Beijing Hospital","startDate":"2022-01-01","conditions":["Coronary Stent Occlusion"],"enrollment":150,"completionDate":"2024-06-01"},{"nctId":"NCT05713019","phase":"NA","title":"ATP and P2X3 Receptor in Chronic Cough","status":"UNKNOWN","sponsor":"Imperial College London","startDate":"2023-02-28","conditions":["Cough"],"enrollment":20,"completionDate":"2024-08-31"},{"nctId":"NCT02987959","phase":"PHASE2","title":"Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas","status":"TERMINATED","sponsor":"Fox Chase Cancer Center","startDate":"2017-02-21","conditions":["Soft-tissue Sarcoma"],"enrollment":6,"completionDate":"2020-07-24"},{"nctId":"NCT05100589","phase":"NA","title":"Effect of PeakATP on Mood, Reaction Time and Cognition","status":"COMPLETED","sponsor":"University of Central Florida","startDate":"2021-10-06","conditions":["Cognitive Change","Mood"],"enrollment":35,"completionDate":"2022-04-19"},{"nctId":"NCT02721537","phase":"NA","title":"Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-09","conditions":["Concussion, Mild"],"enrollment":30,"completionDate":"2022-08"},{"nctId":"NCT04116606","phase":"PHASE2","title":"Antidepressant Trial With P2X7 Antagonist JNJ-54175446","status":"UNKNOWN","sponsor":"CCTU-Core","startDate":"2019-09-12","conditions":["Depressive Disorder, Major","Inflammation"],"enrollment":142,"completionDate":"2024-06-30"},{"nctId":"NCT01306994","phase":"","title":"Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related Conditions","status":"WITHDRAWN","sponsor":"Freeman-Sheldon Research Group, Inc.","startDate":"2014-03","conditions":["Arthrogryposis","Craniofacial Abnormalities"],"enrollment":0,"completionDate":"2022-06"},{"nctId":"NCT02626507","phase":"PHASE1","title":"Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer","status":"UNKNOWN","sponsor":"Hoffman Oncology","startDate":"2016-01","conditions":["Breast Cancer"],"enrollment":18,"completionDate":"2022-03-15"},{"nctId":"NCT03972683","phase":"EARLY_PHASE1","title":"Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training","status":"WITHDRAWN","sponsor":"Colorado State University","startDate":"2019-04-16","conditions":["Vasoconstriction","Vasodilation"],"enrollment":0,"completionDate":"2021-07-31"},{"nctId":"NCT03738943","phase":"EARLY_PHASE1","title":"Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2019-02-07","conditions":["Receptor Blockade"],"enrollment":9,"completionDate":"2021-06-01"},{"nctId":"NCT03167788","phase":"PHASE2","title":"Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery","status":"WITHDRAWN","sponsor":"University of Leicester","startDate":"2020-12","conditions":["Organ Failure, Multiple","Inflammation","Sepsis"],"enrollment":0,"completionDate":"2020-12"},{"nctId":"NCT04744753","phase":"PHASE4","title":"AOA in Recurrent Fertilization Failure","status":"COMPLETED","sponsor":"MOHAMED BEHERY","startDate":"2017-07-15","conditions":["Infertility Primary"],"enrollment":150,"completionDate":"2018-11-17"},{"nctId":"NCT03647670","phase":"PHASE1","title":"A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-07-03","conditions":["Phase 1"],"enrollment":25,"completionDate":"2018-10-16"},{"nctId":"NCT03662516","phase":"PHASE1","title":"A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-09-26","conditions":["Healthy Females"],"enrollment":17,"completionDate":"2019-01-19"},{"nctId":"NCT02619669","phase":"PHASE1","title":"Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer","status":"WITHDRAWN","sponsor":"Gary Schwartz","startDate":"2017-04-20","conditions":["Breast Cancer"],"enrollment":0,"completionDate":"2019-06-14"},{"nctId":"NCT02580253","phase":"PHASE2","title":"Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation","status":"WITHDRAWN","sponsor":"Zhejiang University","startDate":"2017-11-01","conditions":["Hepatocellular Carcinoma"],"enrollment":0,"completionDate":"2018-12"},{"nctId":"NCT03638063","phase":"","title":"ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2018-10-29","conditions":["Chronic Cough","Bronchiectasis"],"enrollment":200,"completionDate":"2020-07"},{"nctId":"NCT01499069","phase":"NA","title":"Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-02","conditions":["Overactive Bladder"],"enrollment":191,"completionDate":"2016-02"},{"nctId":"NCT02789358","phase":"NA","title":"A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2015-12","conditions":["Atrial Fibrillation"],"enrollment":140,"completionDate":"2016-08"},{"nctId":"NCT01072175","phase":"PHASE2","title":"Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-03-26","conditions":["Cancer"],"enrollment":430,"completionDate":"2018-02-27"},{"nctId":"NCT03477747","phase":"NA","title":"The Application of Microcurrent in Athletes","status":"COMPLETED","sponsor":"University of Greenwich","startDate":"2018-01-02","conditions":["Training Group, Sensitivity"],"enrollment":30,"completionDate":"2018-12-31"},{"nctId":"NCT02659397","phase":"PHASE2","title":"A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg","status":"COMPLETED","sponsor":"Esperion Therapeutics, Inc.","startDate":"2015-12","conditions":["Hyperlipidemia"],"enrollment":68,"completionDate":"2016-07"},{"nctId":"NCT02341456","phase":"PHASE1","title":"Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-01-16","conditions":["Advanced Solid Tumours"],"enrollment":19,"completionDate":"2018-07-09"},{"nctId":"NCT03877523","phase":"NA","title":"Cocarnit Effects on Macrophages Polarization","status":"COMPLETED","sponsor":"Institute for Atherosclerosis Research, Russia","startDate":"2018-10-03","conditions":["Diabetes Mellitus, Type 2","Diabetes Complications"],"enrollment":40,"completionDate":"2018-12-20"},{"nctId":"NCT02948335","phase":"","title":"Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-02-23","conditions":["Infection"],"enrollment":22,"completionDate":"2018-02-19"},{"nctId":"NCT01919918","phase":"PHASE1","title":"Muscle Afferent Feedback Effects in Patients With Heart Failure","status":"COMPLETED","sponsor":"University of Utah","startDate":"2013-09","conditions":["Chronic Heart Failure"],"enrollment":144,"completionDate":"2018-01-03"},{"nctId":"NCT01477983","phase":"PHASE4","title":"Kansai Plus Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2011-11","conditions":["Atrial Fibrillation"],"enrollment":2113,"completionDate":"2017-07"},{"nctId":"NCT02286778","phase":"PHASE2,PHASE3","title":"Eradication of Malignant Carcinoma in the Breast Tissue","status":"COMPLETED","sponsor":"Optimal Health Research","startDate":"2016-02","conditions":["Breast Cancer"],"enrollment":60,"completionDate":"2017-08-01"},{"nctId":"NCT01508338","phase":"NA","title":"The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes","status":"COMPLETED","sponsor":"Metabolic Technologies Inc.","startDate":"2012-01","conditions":["Healthy Experienced Weight Training Males"],"enrollment":44,"completionDate":"2012-10"},{"nctId":"NCT03169413","phase":"","title":"Gene Study for Infantile Onset Diabetes","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-01","conditions":["Study Genetic Basis of Infantile Onset Diabetes Mellitus"],"enrollment":100,"completionDate":"2020-08"},{"nctId":"NCT00181155","phase":"PHASE2","title":"Intravenous Allopurinol in Heart Failure","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2004-11","conditions":["Congestive Heart Failure"],"enrollment":18,"completionDate":"2010-12"},{"nctId":"NCT03138681","phase":"PHASE2","title":"Rapid Antidepressant Effects of ATP and Phosphocreatine","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2017-05-03","conditions":["Major Depressive Disorder"],"enrollment":42,"completionDate":"2019-04-30"},{"nctId":"NCT01307475","phase":"","title":"Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions","status":"TERMINATED","sponsor":"Freeman-Sheldon Research Group, Inc.","startDate":"2011-02","conditions":["Arthrogryposis","Craniofacial Abnormalities","Posttraumatic Stress Disorder","Depressive Disorder"],"enrollment":6,"completionDate":"2017-04-01"},{"nctId":"NCT02087241","phase":"PHASE2","title":"Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2014-03","conditions":["Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer"],"enrollment":22,"completionDate":"2015-06"},{"nctId":"NCT02279511","phase":"PHASE2","title":"ATP in Alzheimer Disease","status":"COMPLETED","sponsor":"Sara Varea","startDate":"2014-12","conditions":["Alzheimer's Disease"],"enrollment":20,"completionDate":"2016-02"},{"nctId":"NCT01275274","phase":"PHASE2","title":"Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens","status":"WITHDRAWN","sponsor":"University of North Carolina, Chapel Hill","startDate":"2012-01","conditions":["Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"],"enrollment":0,"completionDate":"2013-12"},{"nctId":"NCT00565188","phase":"PHASE3","title":"Application of ATP Infusions in Palliative Home Care","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2002-03","conditions":["Cancer","Palliative Care","Survival","Quality of Life"],"enrollment":100,"completionDate":"2006-10"},{"nctId":"NCT01855373","phase":"NA","title":"Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements","status":"COMPLETED","sponsor":"Supplement Formulators, Inc.","startDate":"2012-07","conditions":["Blood Sugar","Endothelial Function"],"enrollment":60,"completionDate":"2016-04"},{"nctId":"NCT00774852","phase":"PHASE2","title":"Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-11","conditions":["Lupus Nephritis","Lupus Erythematosus, Systemic"],"enrollment":137,"completionDate":"2014-06"},{"nctId":"NCT02093611","phase":"NA","title":"Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Following a Repeated Sprint Bout","status":"COMPLETED","sponsor":"Metabolic Technologies Inc.","startDate":"2013-07","conditions":["Muscle Fatigue Caused by Repetitive Muscle Exercise"],"enrollment":42,"completionDate":"2015-08"},{"nctId":"NCT00917696","phase":"PHASE1","title":"Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-10","conditions":["Osteoarthritis Pain"],"enrollment":44,"completionDate":"2011-06"},{"nctId":"NCT02018848","phase":"NA","title":"Internet-delivered Attention Training for Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"Humboldt-Universität zu Berlin","startDate":"2013-10","conditions":["Obsessive-Compulsive Disorder"],"enrollment":108,"completionDate":"2014-07"},{"nctId":"NCT02255006","phase":"NA","title":"Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2014-05","conditions":["Healthy"],"enrollment":36,"completionDate":"2014-12"},{"nctId":"NCT01992627","phase":"NA","title":"Clinical Trial for High Intensity Laser Therapy (HILT) for Elbow Epicondylosis","status":"UNKNOWN","sponsor":"CM Chungmu Hospital","startDate":"2013-10","conditions":["Chronic Pain","Elbow Tenderness","Elbow Pain Upon Active Resistive Motion"],"enrollment":40,"completionDate":"2013-12"},{"nctId":"NCT01817972","phase":"PHASE3","title":"Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease","status":"UNKNOWN","sponsor":"Gastroenterology Research of America","startDate":"2013-03","conditions":["Crohn's Disease"],"enrollment":65,"completionDate":"2014-11"},{"nctId":"NCT00014248","phase":"PHASE1","title":"Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2000-10","conditions":["Cachexia","Unspecified Adult Solid Tumor, Protocol Specific"],"enrollment":0,"completionDate":""},{"nctId":"NCT01012284","phase":"PHASE1","title":"A Study of TMC207 in Patients With Moderately Impaired Hepatic Function","status":"COMPLETED","sponsor":"Tibotec BVBA","startDate":"2010-01","conditions":["Moderate Hepatic Impairment"],"enrollment":16,"completionDate":"2011-01"},{"nctId":"NCT01205230","phase":"PHASE4","title":"VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-09","conditions":["Cancer"],"enrollment":34,"completionDate":"2011-08"},{"nctId":"NCT01141504","phase":"PHASE1","title":"Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance","status":"COMPLETED","sponsor":"Metabolic Technologies Inc.","startDate":"2010-06","conditions":["Healthy Subjects"],"enrollment":16,"completionDate":"2011-10"},{"nctId":"NCT01392833","phase":"PHASE3","title":"Steroids and Azathioprine in Advanced IgAN","status":"COMPLETED","sponsor":"A. Manzoni Hospital","startDate":"1999-12","conditions":["IgA Nephropathy","Chronic Kidney Disease"],"enrollment":46,"completionDate":"2008-01"},{"nctId":"NCT01130428","phase":"PHASE1,PHASE2","title":"Mechanical Bone Stimulation and Adenosine 5'-Triphosphate (ATP) Release in Humans","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2010-10","conditions":["Osteoporosis"],"enrollment":10,"completionDate":"2010-12"},{"nctId":"NCT00755859","phase":"PHASE4","title":"\"Steroids and Azathioprine Versus Steroids Alone in IgAN\"","status":"COMPLETED","sponsor":"A. Manzoni Hospital","startDate":"1998-05","conditions":["IGA Nephropathy"],"enrollment":206,"completionDate":"2007-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"NUI":"N0000180300","MMSL":"4135","NDDF":"003603","UNII":"8L70Q75FXE","VUID":"4029344","CHEBI":"CHEBI:15422","VANDF":"4019507","RXNORM":"296","UMLSCUI":"C0001480","chemblId":"CHEMBL2106579","ChEMBL_ID":"CHEMBL14249","KEGG_DRUG":"D02300","DRUGBANK_ID":"DB00171","PDB_CHEM_ID":" ADN","PUBCHEM_CID":"5957","SNOMEDCT_US":"108502004","IUPHAR_LIGAND_ID":"1713","MESH_DESCRIPTOR_UI":"D000255"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":26446,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 23","pmid":"41905068","title":"Investigation of the effects and underlying mechanisms of adenylate kinase 1 on inosine monophosphate deposition in Beijing-You chickens.","journal":"Poultry science"},{"date":"2026","pmid":"41904006","title":"Understanding the impact of cytoskeleton disruption on synaptic plasticity in Alzheimer's disease.","journal":"Advances in protein chemistry and structural biology"},{"date":"2026 Mar 28","pmid":"41902752","title":"Bioinspired Nanofluidic Temperate Synthesis.","journal":"Accounts of chemical research"},{"date":"2026 Apr","pmid":"41902561","title":"Impact of Slaughter-Induced Stress on Biochemical Deterioration and Flavor Stability of Greater Amberjack (Seriola dumerili) Fillets During Iced Storage.","journal":"Journal of food science"},{"date":"2026 Apr","pmid":"41902426","title":"Electrostatic Charge Shielding Effect of ATP: Implications for Therapeutic Intervention.","journal":"Journal of neurochemistry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-19T23:20:21.493931+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}